Breaking NewsMiami Clinic Sued for Selling Banned Drugs to Players

Miami Clinic Sued for Selling Banned Drugs to Players

On Friday, Major League Baseball filed a lawsuit against the owner of Miami-based clinic Biogenesis of America, and its owner, Anthony Bosch along with including several of his former business partners as defendants. The complaint alleged that the clinic damaged the sports of baseball by providing banned drugs to a number of professional baseball players.

The lawsuit was filed in Florida state court and follows an investigation made by a weekly Miami newspaper in the activities of the clinic, which revealed hand-written records. The defendants are accused of interfering with MLB’s drug prevention and treatment program, which prohibits players from using performance-enhancing drugs.

Court documents mentioned at least six players including New York Yankees shortstop Alex Rodriguez, and Texas Rangers slugger Nelson Cruz. Other players named in the documents included Marcelo Albir, a former baseball player for the University of Miami.

Sponsored by LC  
What
Where


However, none of the players were defendants in the actual lawsuit, and all of them have previously denied any association with either Biogenesis or Bosch.

The lawsuit also mentioned one Jan Carlos Nunez, who used to act as a link between the clinic and the agents for several baseball players, and it also mentioned one Paulo da Silveira who allegedly provided drugs to Biogenesis.

The lawsuit asks for “monetary damages and other relief resulting from the defendants’ tortuous interference with MLB’s contractual relationships” and alleges that the defendants hurt the sports of baseball due to “the costs of investigation, loss of goodwill, loss of revenue and profits, and injury to its reputation.”

Most Popular Articles

Related Articles

RECENT COMMENTS

LEAVE A REPLY

Please enter your comment!
Please enter your name here

 

Top Legal Job

Most Popular

Legal Career Resources

Subscribe to Newsletter

Subscribe or use your Google/Facebook account to continue

Thank you for subscribing!